Description
Dosing pen Royal Peptides – CJC-1295 + DAC 5mg/2ml (GHRH Analog with Extended Half-Life)
CJC-1295 + DAC is an advanced experimental peptide compound belonging to the category of growth hormone-releasing hormone (GHRH) secretagogues. It is a modified peptide of tetra-substituted GRF (1-29), to which the DAC (Drug Affinity Complex) is chemically attached. This unique technological modification allows the peptide to bind to blood albumin, significantly extending its stability and bioavailability in the body—from hours to several days. In scientific research, this molecule is highly valued for its ability to maintain consistently elevated levels of growth hormone (GH) and insulin-like growth factor 1 (IGF-1) without the need for frequent administration.
The dosing pen contains 5 mg of highly purified active substance in 2 ml of solution, corresponding to a concentration of exactly 2.5 mg/ml. Calculated for precise dosing within research protocols:
1 ml = 100 units (UI) = 100 clicks
0.5 ml (one full rotation of the mechanism) = 50 clicks
Examples of dosing for research purposes:
1 click = 0.025 mg (25 mcg) of active substance
4 clicks = 0.10 mg (100 mcg) of active substance
10 clicks (0.1 ml) = 0.25 mg (250 mcg) of active substance
20 clicks (0.2 ml) = 0.50 mg (500 mcg) of active substance
40 clicks (0.4 ml) = 1.00 mg (1000 mcg) of active substance
50 clicks (0.5 ml / full rotation) = 1.25 mg (1250 mcg) of active substance
This mechanical system ensures absolute precision, repeatability, and flexibility when setting microdoses according to the requirements of a specific laboratory protocol, without the need for manual dilution.
Effects Investigated by Research
In the field of endocrinological and metabolic research, CJC-1295 + DAC is studied for its specific effect on the anterior pituitary gland. Unlike non-DAC versions, which cause short-term, pulsatile release of growth hormone, this compound induces a so-called “basal elevation” of GH levels.
Studies suggest that prolonged elevated levels of circulating IGF-1 support protein synthesis, accelerate the regeneration of connective tissues, tendons, and muscle cells after traumatic injury. At the same time, research is ongoing into its effects on lipolysis (fat breakdown), improvement of bone density (mineralization), and overall optimization of deep sleep phases, during which the most significant cellular repair processes occur.
Scientific Context and Sources
The pharmacokinetics and biological properties of CJC-1295 with the DAC complex have been extensively mapped and published in reputable endocrinology journals such as The Journal of Clinical Endocrinology & Metabolism, and data are freely available in academic databases such as PubMed. Research protocols confirm that the DAC modification prevents rapid enzymatic degradation of the peptide.
Additional information on long-term effects on lipid metabolism and cellular nitrogen balance is collected in academic studies registered in the ClinicalTrials.gov database, where the safe therapeutic potential of secretagogues in the treatment of growth hormone deficiency is being analyzed.
The Royal Peptides dosing pen provides a modern, safe, and highly sterile solution for handling this advanced molecule under controlled laboratory conditions.
The product is intended exclusively for scientific and research purposes. Not for direct human consumption.




